Novartis says reaches agreement to buy Texas-based Encore Vision

ZURICH (Reuters) - Swiss drugmaker Novartis said on Tuesday it has reached a definitive agreement to buy Fort Worth, Texas-based Encore Vision, which is focused on developing a novel treatment in presbyopia, or far-sightedness.

Novartis says reaches agreement to buy Texas-based Encore Vision
Read More


Bagikan Berita Ini